• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Recent Advances in the Synthesis and Applications of tert-Butyl N-[(3R)-2-oxooxetan-3-yl]carbamate (CAS: 126330-77-6)

The compound tert-butyl N-[(3R)-2-oxooxetan-3-yl]carbamate (CAS: 126330-77-6) has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile role as a key intermediate in the synthesis of β-lactam antibiotics and other bioactive molecules. Recent studies have focused on optimizing its synthetic pathways, exploring its mechanistic roles, and expanding its applications in drug discovery and development. This research brief consolidates the latest findings and advancements related to this compound, providing a comprehensive overview for professionals in the field.

One of the most notable developments in the synthesis of tert-butyl N-[(3R)-2-oxooxetan-3-yl]carbamate involves the use of enantioselective catalytic methods. A 2023 study published in the Journal of Organic Chemistry demonstrated a highly efficient asymmetric synthesis route using chiral palladium catalysts, achieving an enantiomeric excess (ee) of over 98%. This method not only improves yield and purity but also reduces the environmental impact compared to traditional synthetic approaches. The study highlights the potential for scalable production, which is critical for industrial applications.

In addition to synthetic advancements, researchers have investigated the mechanistic role of tert-butyl N-[(3R)-2-oxooxetan-3-yl]carbamate in the formation of β-lactam rings, a structural motif prevalent in antibiotics such as penicillins and cephalosporins. A recent publication in ACS Medicinal Chemistry Letters elucidated the compound's ability to act as a precursor for strained heterocycles, which are essential for enhancing the biological activity of target molecules. The study employed density functional theory (DFT) calculations to map the reaction pathways, providing valuable insights into the compound's reactivity and stability under varying conditions.

Furthermore, the application of tert-butyl N-[(3R)-2-oxooxetan-3-yl]carbamate has expanded beyond traditional antibiotic synthesis. A 2024 report in Nature Chemical Biology highlighted its use in the development of proteolysis-targeting chimeras (PROTACs), a promising therapeutic modality for targeted protein degradation. The compound's unique structural features enable its incorporation into bifunctional molecules that recruit E3 ubiquitin ligases, facilitating the degradation of disease-causing proteins. This innovative application underscores the compound's potential in addressing previously undruggable targets.

Despite these advancements, challenges remain in the large-scale production and functionalization of tert-butyl N-[(3R)-2-oxooxetan-3-yl]carbamate. Recent studies have identified issues related to regioselectivity and byproduct formation during multi-step syntheses. However, emerging technologies such as flow chemistry and biocatalysis offer promising solutions to these challenges. For instance, a 2023 study in Green Chemistry demonstrated the use of immobilized enzymes to achieve high-yield conversions with minimal waste, paving the way for more sustainable manufacturing processes.

In conclusion, tert-butyl N-[(3R)-2-oxooxetan-3-yl]carbamate (CAS: 126330-77-6) continues to be a focal point of research in chemical biology and pharmaceutical sciences. Its role as a versatile intermediate, coupled with recent breakthroughs in synthesis and application, positions it as a critical component in the development of next-generation therapeutics. Ongoing research efforts are expected to further unlock its potential, addressing current limitations and expanding its utility in drug discovery and beyond.

• 91103-47-8(Boc-D-Ala-OMe)
• 95715-85-8(Boc-D-ser-ome)
• 98541-64-1(tert-butyl N-[(3S)-2-oxooxetan-3-yl]carbamate)
• 2766-43-0(Boc-Ser-OMe)
• 61172-70-1(Propanedioic acid,2-[[(1,1-dimethylethoxy)carbonyl]amino]-, 1,3-dimethyl ester)
• 61172-71-2((1,1-Dimethylethoxy)carbonylamino-monomethyl Ester Propanedioic Acid)
• 28875-17-4(Boc-Ala-OMe)
• 7738-22-9((S)-tert-Butyl 2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoate)
• 833484-34-7(Carbamic acid, (3-methyl-2-oxo-3-oxetanyl)-, 1,1-dimethylethyl ester)
• 7801-80-1(3-(acetyloxy)-2-{(tert-butoxy)carbonylamino}propanoic acid)